Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C MutationFerdinandos Skoulidis, Ramaswamy Govindan, Bob T. Li et al.|New England Journal of Medicine|2021Cited by 1.8k
Prospective Validation of Rapid Plasma Genotyping for the Detection of<i>EGFR</i>and<i>KRAS</i>Mutations in Advanced Lung CancerAdrian G. Sacher, Geoffrey R. Oxnard, Cloud P. Paweletz et al.|JAMA Oncology|2016Cited by 567
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell CarcinomaSumanta K. Pal, Samer A. Srour, Ben Tran et al.|Cancer Discovery|2024Cited by 137
Durvalumab therapy following chemoradiation compared with a historical cohort treated with chemoradiation alone in patients with stage III non–small cell lung cancer: A real-world multicentre studyAntoine Desîlets, Arielle Elkrief, Wiam Belkaïd et al.|European Journal of Cancer|2020Cited by 78
Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung CancerMiguel García-Pardo, Natasha B. Leighl, Kasia Czarnecka‐Kujawa et al.|JAMA Network Open|2023Cited by 60